CM – Is Biondvax Pharmaceuticals Ltd – ADR (BVXV) stock worth buying on Wednesday?


The stock of Biondvax Pharmaceuticals Ltd – ADR (BVXV) is down -9.38% in the past 12 months. InvestorsObserver’s proprietary ranking system gives BVXV shares a score of 19 out of a possible 100.

This rank is mainly influenced by a fundamental value of 0. . The rank of BVXV also includes a long term technical score of 19. The short term technical score for BVXV is 37.

Copyright © 2021. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer and / or O2 Media LLC. All rights reserved. Portions of this content are protected by U.S. Patent Nos. 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, options, and other financial instruments carries risks and may not be suitable for everyone. The portfolio results are unaudited and are based on different expiration dates of the plant. Terms of Use | Privacy Policy



Donnez votre avis et abonnez-vous pour plus d’infos



[supsystic-newsletter-form id=4]

Vidéo du jour: